10X Genomics Inc Class A (TXG)
Deferred Revenue
$23.61M
Quarterly · Period ending: · USD
TXG Deferred Revenue
Latest reported$23.61Mperiod ending
Latest reported$23.61Mperiod ending
TXG Quarterly Deferred Revenue ($0.00 → $23.61M)
Quarterly deferred revenue
High-resolution chart · PNG
TXG deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 23,610,000 | |
| 24,342,000 | |
| 23,902,000 | |
| 22,139,000 | |
| 21,449,000 | |
| 20,949,000 | |
| 20,658,000 | |
| 17,760,000 | |
| 16,436,000 | |
| 14,296,000 | |
| 13,150,000 | |
| 11,143,000 | |
| 9,217,000 | |
| 8,530,000 | |
| 7,867,000 | |
| 7,826,000 | |
| 7,361,000 | |
| 6,260,000 | |
| 5,340,000 | |
| 6,467,000 | |
| 6,372,000 | |
| 5,900,000 | |
| 4,472,000 | |
| 4,875,000 | |
| 4,357,000 | |
| 4,470,000 | |
| 4,601,000 | |
| 3,082,000 | |
| 3,236,000 | |
| 0 | |
| 2,776,000 | |
| 0 |